Artiva Biotherapeutics, Inc. (ARTV)

Artiva Biotherapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Artiva Biotherapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022
Debt / Equity Ratio	-0.09	-0.10	-0.14
Debt / EBITDA Ratio	-0.63	-0.58	-0.33
Debt / FCF Ratio	-0.33	-0.33	-0.34
Quick Ratio	6.16	6.44	4.02
Return on Equity (ROE)	14.87%	17.73%	41.78%
Return on Assets (ROA)	-	-27.32%	-44.18%
Return on Capital (ROIC)	17.34%	21.14%	49.34%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).